Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,751 | 308 | 79.4% |
| Travel and Lodging | $2,179 | 7 | 19.8% |
| Education | $85.00 | 1 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teleflex LLC | $1,687 | 15 | $0 (2024) |
| NeoTract Inc. | $1,339 | 5 | $0 (2019) |
| CIPLA USA INC. | $906.90 | 3 | $0 (2021) |
| Dendreon Pharmaceuticals LLC | $716.63 | 22 | $0 (2024) |
| Boston Scientific Corporation | $599.86 | 11 | $0 (2024) |
| Astellas Pharma US Inc | $408.43 | 24 | $0 (2024) |
| Antares Pharma, Inc. | $399.83 | 26 | $0 (2023) |
| COLOPLAST CORP | $345.10 | 12 | $0 (2024) |
| Blue Earth Diagnostics Limited | $250.19 | 7 | $0 (2024) |
| Endo Pharmaceuticals Inc. | $249.18 | 13 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,114 | 60 | Dendreon Pharmaceuticals LLC ($673.06) |
| 2023 | $1,245 | 45 | PROCEPT BioRobotics Corporation ($219.34) |
| 2022 | $2,133 | 58 | Teleflex LLC ($1,113) |
| 2021 | $2,322 | 49 | CIPLA USA INC. ($906.90) |
| 2020 | $418.17 | 22 | Coloplast Corp ($152.92) |
| 2019 | $1,619 | 18 | NeoTract Inc. ($1,323) |
| 2018 | $629.72 | 29 | Endo Pharmaceuticals Inc. ($163.13) |
| 2017 | $534.29 | 35 | Astellas Pharma US Inc ($156.02) |
All Payment Transactions
316 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 12/10/2024 | Theragenics Corporation | — | Food and Beverage | Cash or cash equivalent | $157.66 | General |
| 12/10/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $24.76 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 12/04/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $33.36 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 11/25/2024 | Blue Earth Diagnostics Limited | POSLUMA (Drug) | Food and Beverage | In-kind items and services | $24.38 | General |
| Category: Diagnostic Imaging | ||||||
| 11/22/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $29.63 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 11/12/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $25.94 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 11/11/2024 | Stryker Corporation | 1788 (Medical Supply) | Food and Beverage | In-kind items and services | $38.57 | General |
| Category: ENDOSCOPY | ||||||
| 11/04/2024 | Laborie Medical Technologies Corp. | Optilume BPH Drug Coated Balloon Catheter (Device) | Food and Beverage | Cash or cash equivalent | $18.41 | General |
| Category: Urology | ||||||
| 11/04/2024 | Laborie Medical Technologies Corp. | Optilume BPH Drug Coated Balloon Catheter (Device) | Food and Beverage | Cash or cash equivalent | $0.78 | General |
| Category: Urology | ||||||
| 11/04/2024 | Laborie Medical Technologies Corp. | Optilume BPH Drug Coated Balloon Catheter (Device) | Food and Beverage | Cash or cash equivalent | $0.68 | General |
| Category: Urology | ||||||
| 10/23/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $33.77 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 10/18/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $23.71 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 10/16/2024 | COLOPLAST CORP | Altis (Device) | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: Women's Health | ||||||
| 10/04/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $22.04 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 09/25/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: ONCOLOGY | ||||||
| 09/17/2024 | Teleflex LLC | — | Food and Beverage | In-kind items and services | $21.56 | General |
| 09/06/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $22.93 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 08/27/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $20.01 | General |
| Category: Oncology | ||||||
| 08/21/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $26.14 | General |
| Category: UROLOGY | ||||||
| 08/19/2024 | Laborie Medical Technologies Corp. | Optilume BPH Drug Coated Balloon Catheter (Device) | Food and Beverage | Cash or cash equivalent | $15.59 | General |
| Category: Urology | ||||||
| 08/16/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $31.93 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 08/09/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $23.60 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 07/16/2024 | Blue Earth Diagnostics Limited | POSLUMA (Drug) | Food and Beverage | In-kind items and services | $121.05 | General |
| Category: Diagnostic Imaging | ||||||
| 07/09/2024 | PFIZER INC. | PADCEV (Biological) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 52 | 6,569 | 21,843 | $1.6M | $369,220 |
| 2022 | 55 | 6,697 | 23,538 | $1.9M | $433,176 |
| 2021 | 55 | 6,598 | 17,658 | $1.6M | $382,217 |
| 2020 | 65 | 7,234 | 26,066 | $2.4M | $557,756 |
All Medicare Procedures & Services
235 procedure records from CMS Medicare Utilization — Page 1 of 10
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 643 | 1,047 | $267,351 | $85,263 | 31.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 597 | 853 | $146,665 | $50,443 | 34.4% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 131 | 150 | $94,514 | $23,229 | 24.6% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 11 | 1,020 | $38,270 | $18,875 | 49.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 139 | 139 | $54,578 | $14,624 | 26.8% |
| J3490 | Unclassified drugs | Office | 2023 | 16 | 27 | $30,326 | $14,115 | 46.5% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 20 | 94 | $64,198 | $12,660 | 19.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 229 | 261 | $26,880 | $9,843 | 36.6% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 388 | 511 | $34,395 | $9,208 | 26.8% |
| 74178 | Ct scan of abdomen and pelvis before and after contrast | Office | 2023 | 52 | 52 | $42,748 | $8,908 | 20.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 792 | 884 | $13,790 | $7,426 | 53.8% |
| J9155 | Injection, degarelix, 1 mg | Office | 2023 | 17 | 2,320 | $16,908 | $7,020 | 41.5% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 1,134 | 2,228 | $25,711 | $6,898 | 26.8% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 179 | 250 | $23,615 | $6,323 | 26.8% |
| 74176 | Ct scan of abdomen and pelvis without contrast | Office | 2023 | 74 | 78 | $39,810 | $5,558 | 14.0% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 14 | 17 | $25,516 | $5,388 | 21.1% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 53 | 54 | $18,937 | $5,343 | 28.2% |
| 50590 | Shock wave crushing of kidney stones | Facility | 2023 | 12 | 12 | $20,696 | $4,944 | 23.9% |
| 52441 | Insertion of implant in urethra within prostate gland using an endoscope, 1 implant | Facility | 2023 | 29 | 29 | $75,540 | $4,510 | 6.0% |
| 64566 | Insertion of lower leg neurostimulator electrode | Office | 2023 | 22 | 57 | $18,242 | $4,342 | 23.8% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 71 | 73 | $26,578 | $4,320 | 16.3% |
| 52442 | Insertion of implant in urethra within prostate gland using an endoscope, each additional implant | Facility | 2023 | 29 | 108 | $214,731 | $4,070 | 1.9% |
| 53899 | Other procedure on urinary system | Office | 2023 | 32 | 32 | $24,960 | $4,055 | 16.2% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 401 | 581 | $28,097 | $3,989 | 14.2% |
| 74018 | X-ray of abdomen, 1 view | Office | 2023 | 146 | 203 | $13,211 | $3,951 | 29.9% |
About Richard Young, DR
Richard Young, DR is a Urology healthcare provider based in Myrtle Beach, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/08/2005. The National Provider Identifier (NPI) number assigned to this provider is 1518948587.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Richard Young, DR has received a total of $11,015 in payments from pharmaceutical and medical device companies, with $2,114 received in 2024. These payments were reported across 316 transactions from 67 companies. The most common payment nature is "Food and Beverage" ($8,751).
As a Medicare-enrolled provider, Young has provided services to 27,098 Medicare beneficiaries, totaling 89,105 services with total Medicare billing of $1.7M. Data is available for 4 years (2020–2023), covering 235 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Myrtle Beach, SC
- Active Since 11/08/2005
- Last Updated 12/29/2016
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1518948587
Products in Payments
- UROLIFT (Device) $2,178
- ZEMDRI (PLAZOMICIN) (Drug) $906.90
- UroLift System (Device) $786.11
- PROVENGE (Drug) $716.63
- GENERAL KIDNEY STONE DISEASE (Device) $391.71
- XTANDI (Drug) $291.83
- XIAFLEX (Biological) $249.18
- AQUABEAM ROBOTIC SYSTEM (Device) $219.34
- GEMTESA (Drug) $218.73
- JELMYTO (Drug) $212.00
- ERLEADA (Drug) $173.28
- POSLUMA (Drug) $171.10
- Consumables & Accessories (Device) $155.73
- XYOSTED (Drug) $154.72
- INTERSTIM (Device) $145.32
- TITAN (Device) $141.81
- BOTOX (Biological) $141.19
- NOCDURNA (Drug) $139.62
- FOUNDATIONONE (Device) $136.96
- Swiss LithoClast Triology (Device) $131.21
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Myrtle Beach
Dr. Neal Shore, Dr, DR
Urology — Payments: $3.7M
Dr. William Bogache, Md, MD
Urology — Payments: $82,917
Dr. Abhishek Srivastava, M.d, M.D
Urology — Payments: $31,006
Dr. Brian Roberts, Md, MD
Urology — Payments: $19,149
Dr. Kenneth Krzyzaniak, Md, MD
Urology — Payments: $8,180
Dr. Lauren Cooley, M.d, Ph.d, M.D, PH.D
Urology — Payments: $4,468